Scripps 6th Annual Cardiomyopathy and Cardio-Oncology Symposium 2023 (Videos + PDF)

Advanced Cardiomyopathy, Cardiac Amyloidosis & Cardio-Oncology Update

The Scripps 6th Annual Cardiomyopathy and Cardio-Oncology Symposium 2023 is a comprehensive educational program designed to provide clinicians with the latest evidence-based strategies for diagnosing, monitoring, and managing cardiomyopathies and cardiovascular complications associated with cancer therapies. This state-of-the-art symposium brings together nationally recognized experts in cardiology, oncology, cardiac imaging, heart failure, genetics, and cardio-oncology to explore emerging treatments, innovative diagnostic approaches, and multidisciplinary care models that improve outcomes for patients with cardiovascular disease and cancer.

As cancer survival rates continue to improve, cardiovascular disease has emerged as a major contributor to long-term morbidity and mortality among cancer survivors. Simultaneously, advances in the understanding of cardiac amyloidosis, hypertrophic cardiomyopathy, cardiac sarcoidosis, and inherited cardiomyopathies have transformed clinical practice. This symposium delivers practical, case-based education to help healthcare professionals integrate these advances into patient care.

Product Details

Format: Videos + PDF
Year: 2023
Specialty: Cardiology | Cardio-Oncology | Heart Failure | Cardiomyopathy

Course Overview

The Scripps Cardiomyopathy and Cardio-Oncology Symposium 2023 provides an in-depth review of contemporary approaches to cardiomyopathy and cardiovascular care in oncology patients and cancer survivors. Through expert-led lectures, clinical case discussions, and evidence-based updates, participants gain practical knowledge applicable to both specialty and general cardiovascular practice.

The curriculum focuses on common and emerging cardiomyopathies, cardiac amyloidosis, cardiac sarcoidosis, cancer therapy-related cardiac dysfunction, genetic testing, cardiovascular imaging, venous thromboembolism, and long-term survivorship care. Special emphasis is placed on multidisciplinary collaboration between cardiologists, oncologists, imaging specialists, and advanced practice providers.

Target Audience

This program is designed for:

Physicians

• Cardiologists
• Heart Failure Specialists
• Cardio-Oncology Specialists
• Oncologists
• Hematologists
• Internal Medicine Physicians

Advanced Practice Providers

• Nurse Practitioners (NP)
• Physician Assistants (PA)
• Registered Nurses (RN)

Imaging Professionals

• Sonographers
• Cardiac Imaging Specialists

Trainees

• Cardiology Fellows
• Oncology Fellows
• Internal Medicine Residents

Learning Objectives

Upon completion of this activity, participants should be able to:

• Evaluate current and emerging therapies for cardiac amyloidosis
• Discuss diagnosis and treatment strategies for cardiac sarcoidosis
• Assess the role of genetic testing in inherited cardiomyopathies
• Apply best practices for monitoring cancer therapy-related cardiotoxicity
• Manage cardiovascular complications associated with cancer treatment
• Recognize and treat venous thromboembolism in oncology patients
• Develop long-term surveillance strategies for cancer survivors
• Utilize multidisciplinary approaches to optimize patient outcomes

Major Topics Covered

❤️ Cardiomyopathy Management

Comprehensive Review

• Dilated Cardiomyopathy
• Hypertrophic Cardiomyopathy (HCM)
• Restrictive Cardiomyopathy
• Genetic Cardiomyopathies
• Infiltrative Cardiomyopathies
• Arrhythmogenic Cardiomyopathy

Clinical Focus

• Diagnostic Strategies
• Risk Stratification
• Guideline-Based Therapy
• Long-Term Follow-Up

🧬 Cardiac Amyloidosis

Emerging Diagnostic and Treatment Advances

Cardiac amyloidosis has become one of the fastest-growing areas in cardiovascular medicine due to improved recognition and new disease-modifying therapies.

Topics Covered

• Transthyretin Amyloidosis (ATTR)
• Light Chain (AL) Amyloidosis
• Diagnostic Algorithms
• Nuclear Imaging
• Echocardiography
• Cardiac MRI

Treatment Updates

• Tafamidis Therapy
• Novel ATTR Treatments
• Emerging Clinical Trials
• Multidisciplinary Management

🫀 Cardiac Sarcoidosis

Recognition and Management

Areas Covered

• Clinical Presentation
• Diagnostic Criteria
• PET Imaging
• Cardiac MRI Assessment
• Immunosuppressive Therapy
• Arrhythmia Management

Clinical Challenges

• Early Detection
• Risk Stratification
• Long-Term Monitoring

🧪 Genetic Cardiomyopathies

Precision Cardiovascular Medicine

Topics Include

• Genetic Testing Strategies
• Family Screening Programs
• Hypertrophic Cardiomyopathy Genetics
• Inherited Cardiovascular Disorders
• Interpretation of Genetic Results

Clinical Applications

• Personalized Treatment
• Risk Assessment
• Family Counseling

🎗️ Cardio-Oncology

Cardiovascular Care in Cancer Patients

The symposium provides extensive coverage of cardiovascular complications associated with cancer therapies.

Topics Covered

• Chemotherapy-Induced Cardiotoxicity
• Immunotherapy-Related Cardiac Toxicity
• Radiation-Induced Heart Disease
• Targeted Therapy Complications
• Cancer Treatment Surveillance

Monitoring Strategies

• Baseline Risk Assessment
• Serial Imaging
• Biomarker Monitoring
• Long-Term Follow-Up

🩺 Cardiovascular Toxicity Monitoring

Multidisciplinary Care Approaches

Areas Covered

• Early Detection of Cardiac Dysfunction
• Echocardiographic Surveillance
• Global Longitudinal Strain Imaging
• Biomarker-Based Monitoring
• Treatment Modification Strategies

🩸 Venous Thromboembolism in Cancer

Thrombosis Management

Cancer patients face increased risks of thromboembolic complications.

Topics Include

• Cancer-Associated Thrombosis
• Deep Vein Thrombosis (DVT)
• Pulmonary Embolism (PE)
• Anticoagulation Strategies
• Risk Assessment Models

Clinical Decision Making

• Balancing Bleeding and Thrombosis Risks
• Long-Term Anticoagulation

🫁 Heart Failure in Oncology Patients

Topics Covered

• Cancer Therapy-Related Cardiac Dysfunction
• Heart Failure Prevention
• Guideline-Directed Medical Therapy
• Advanced Heart Failure Management

Emerging Therapies

• SGLT2 Inhibitors
• Modern Heart Failure Pharmacotherapy
• Device-Based Approaches

🔬 Advanced Cardiovascular Imaging

Imaging for Cardiomyopathy and Cardio-Oncology

Modalities Reviewed

• Echocardiography
• Strain Imaging
• Cardiac MRI
• Cardiac CT
• PET Imaging
• Nuclear Cardiology

Clinical Applications

• Amyloidosis Detection
• Sarcoidosis Evaluation
• Cardiotoxicity Monitoring
• Risk Stratification

👨‍⚕️ Cancer Survivor Cardiovascular Health

Long-Term Survivorship Care

Topics Include

• Late Cardiovascular Effects of Cancer Therapy
• Secondary Prevention
• Cardiovascular Risk Reduction
• Ongoing Monitoring Programs

Clinical Importance

• Improving Quality of Life
• Reducing Cardiovascular Mortality
• Optimizing Long-Term Outcomes

📚 Case-Based Learning

A major strength of the symposium is its practical, patient-centered approach.

Clinical Cases Include

• Cardiac Amyloidosis
• Hypertrophic Cardiomyopathy
• Cardiac Sarcoidosis
• Chemotherapy-Induced Cardiomyopathy
• Cancer-Associated Thrombosis
• Heart Failure Management

Interactive Learning

• Diagnostic Challenges
• Treatment Selection
• Multidisciplinary Decision Making

Educational Highlights

Nationally Recognized Faculty

Experts in:

• Cardiology
• Oncology
• Heart Failure
• Cardiac Imaging
• Genetics
• Cardio-Oncology

Evidence-Based Updates

Coverage of the latest:

• Clinical Trials
• Guidelines
• Diagnostic Technologies
• Therapeutic Advances

Practical Clinical Application

Recommendations designed for immediate implementation in patient care.

Why This Course Is Valuable

✔ Comprehensive Cardiomyopathy Review

✔ Advanced Cardiac Amyloidosis Education

✔ Cardiac Sarcoidosis Management

✔ Cardio-Oncology Best Practices

✔ Genetic Cardiomyopathy Evaluation

✔ Cancer Therapy Cardiotoxicity Monitoring

✔ Venous Thromboembolism Management

✔ Advanced Cardiac Imaging Applications

✔ Heart Failure Treatment Updates

✔ Cancer Survivor Cardiovascular Care

✔ Multidisciplinary Care Models

✔ Case-Based Clinical Learning

Who Should Study This Program?

Ideal for:

• Cardiologists
• Oncologists
• Internists
• Heart Failure Specialists
• Cardio-Oncology Providers
• Nurse Practitioners
• Physician Assistants
• Registered Nurses
• Sonographers
• Cardiology Fellows
• Oncology Fellows

Clinical & Educational Value

The Scripps 6th Annual Cardiomyopathy and Cardio-Oncology Symposium 2023 delivers a comprehensive review of contemporary cardiomyopathy and cardio-oncology practice. Through expert faculty instruction, case-based discussions, and evidence-based updates, participants gain practical knowledge needed to diagnose, monitor, and manage cardiovascular disease in both traditional cardiology patients and cancer survivors, ultimately improving long-term patient outcomes.